Nikhil K Khankari1, Patrick T Bradshaw2, Susan E Steck3, Ka He4, Andrew F Olshan1, Jing Shen5, Jiyoung Ahn6,7, Yu Chen6,7, Habibul Ahsan8, Mary Beth Terry9, Susan L Teitelbaum10, Alfred I Neugut9,11, Regina M Santella5, Marilie D Gammon1. 1. Department of Epidemiology, University of North Carolina, Chapel Hill, North Carolina. 2. Department of Nutrition, University of North Carolina, Chapel Hill, North Carolina. 3. Department of Epidemiology and Biostatistics, University of South Carolina, Columbia, South Carolina. 4. Department of Epidemiology and Biostatistics, Indiana University, Bloomington, Indiana. 5. Department of Environmental Health, Columbia University, New York, New York. 6. Department of Population Health, New York University, New York, New York. 7. Department of Environmental Medicine, New York University, New York, New York. 8. Department of Health Studies and Comprehensive Cancer Center, University of Chicago, Chicago, Illinois. 9. Department of Epidemiology, Columbia University, New York, New York. 10. Department of Preventive Medicine, Mount Sinai School of Medicine, New York, New York. 11. Department of Medicine, Columbia University, New York, New York.
Abstract
BACKGROUND: In laboratory experiments, ω-3 polyunsaturated fatty acids (PUFAs) have been found to reduce inflammatory eicosanoids resulting from ω-6 PUFA metabolism via competitive inhibition, and the ω-3-induced cytotoxic environment increases apoptosis and reduces cell growth in breast cancer cells. To the authors' knowledge, epidemiologic investigations regarding whether dietary ω-3 PUFA intake benefits survival after breast cancer are limited and inconsistent. METHODS: The authors used resources from a population-based follow-up study conducted on Long Island, New York, among 1463 women newly diagnosed with first primary breast cancer who were interviewed an average of approximately 3 months after diagnosis to assess risk and prognostic factors, including dietary intake (using a food frequency questionnaire). Vital status was determined through 2011, yielding a median follow-up of 14.7 years and 485 deaths. Adjusted hazard ratios (HRs) and 95% confidence intervals (95% CIs) were estimated using Cox proportional hazards regression. RESULTS: All-cause mortality was reduced among women with breast cancer reporting the highest quartile of intake (compared with never) for tuna (HR, 0.71; 95% CI, 0.55-0.92), other baked/broiled fish (HR, 0.75; 95% CI, 0.58-0.97), and the dietary long-chain ω-3 PUFAs docosahexaenoic acid (HR, 0.71; 95% CI, 0.55-0.92) and eicosapentaenoic acid (HR, 0.75; 95% CI, 0.58-0.97). CONCLUSIONS: All-cause mortality was reduced by 16% to 34% among women with breast cancer who reported a high intake of fish and long-chain ω-3 PUFAs. Long-chain ω-3 PUFA intake from fish and other dietary sources may provide a potential strategy to improve survival after breast cancer.
BACKGROUND: In laboratory experiments, ω-3 polyunsaturated fatty acids (PUFAs) have been found to reduce inflammatory eicosanoids resulting from ω-6 PUFA metabolism via competitive inhibition, and the ω-3-induced cytotoxic environment increases apoptosis and reduces cell growth in breast cancer cells. To the authors' knowledge, epidemiologic investigations regarding whether dietary ω-3 PUFA intake benefits survival after breast cancer are limited and inconsistent. METHODS: The authors used resources from a population-based follow-up study conducted on Long Island, New York, among 1463 women newly diagnosed with first primary breast cancer who were interviewed an average of approximately 3 months after diagnosis to assess risk and prognostic factors, including dietary intake (using a food frequency questionnaire). Vital status was determined through 2011, yielding a median follow-up of 14.7 years and 485 deaths. Adjusted hazard ratios (HRs) and 95% confidence intervals (95% CIs) were estimated using Cox proportional hazards regression. RESULTS: All-cause mortality was reduced among women with breast cancer reporting the highest quartile of intake (compared with never) for tuna (HR, 0.71; 95% CI, 0.55-0.92), other baked/broiled fish (HR, 0.75; 95% CI, 0.58-0.97), and the dietary long-chain ω-3 PUFAsdocosahexaenoic acid (HR, 0.71; 95% CI, 0.55-0.92) and eicosapentaenoic acid (HR, 0.75; 95% CI, 0.58-0.97). CONCLUSIONS: All-cause mortality was reduced by 16% to 34% among women with breast cancer who reported a high intake of fish and long-chain ω-3 PUFAs. Long-chain ω-3 PUFA intake from fish and other dietary sources may provide a potential strategy to improve survival after breast cancer.
Authors: Patrick T Bradshaw; Joseph G Ibrahim; June Stevens; Rebecca Cleveland; Page E Abrahamson; Jessie A Satia; Susan L Teitelbaum; Alfred I Neugut; Marilie D Gammon Journal: Epidemiology Date: 2012-03 Impact factor: 4.822
Authors: Ruth E Patterson; Shirley W Flatt; Vicky A Newman; Loki Natarajan; Cheryl L Rock; Cynthia A Thomson; Bette J Caan; Barbara A Parker; John P Pierce Journal: J Nutr Date: 2010-12-22 Impact factor: 4.798
Authors: Philippe Bougnoux; Nawale Hajjaji; Karine Maheo; Charles Couet; Stephan Chevalier Journal: Prog Lipid Res Date: 2009-08-26 Impact factor: 16.195
Authors: Nicole M Niehoff; Marilie D Gammon; Humberto Parada; Steven D Stellman; Alfred I Neugut; Susan L Teitelbaum Journal: Int J Hyg Environ Health Date: 2019-07-24 Impact factor: 5.840
Authors: Humberto Parada; Susan E Steck; Patrick T Bradshaw; Lawrence S Engel; Kathleen Conway; Susan L Teitelbaum; Alfred I Neugut; Regina M Santella; Marilie D Gammon Journal: J Natl Cancer Inst Date: 2017-01-05 Impact factor: 13.506
Authors: Mostefa Fodil; Vincent Blanckaert; Lionel Ulmann; Virginie Mimouni; Benoît Chénais Journal: Int J Environ Res Public Health Date: 2022-06-28 Impact factor: 4.614
Authors: Saraswoti Khadge; John Graham Sharp; Timothy R McGuire; Geoffrey M Thiele; Paul Black; Concetta DiRusso; Leah Cook; Lynell W Klassen; James E Talmadge Journal: Int Immunopharmacol Date: 2018-11-14 Impact factor: 4.932
Authors: Lauren E McCullough; Jia Chen; Yoon Hee Cho; Nikhil K Khankari; Patrick T Bradshaw; Alexandra J White; Gail Garbowski; Susan L Teitelbaum; Mary Beth Terry; Alfred I Neugut; Hanina Hibshoosh; Regina M Santella; Marilie D Gammon Journal: Breast Cancer Res Treat Date: 2016-03-05 Impact factor: 4.872
Authors: Lauren E McCullough; Jia Chen; Yoon Hee Cho; Nikhil K Khankari; Patrick T Bradshaw; Alexandra J White; Susan L Teitelbaum; Mary Beth Terry; Alfred I Neugut; Hanina Hibshoosh; Regina M Santella; Marilie D Gammon Journal: Breast Cancer Res Date: 2017-02-21 Impact factor: 6.466